Omnitura Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2001-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.omnitura.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Aneustat Treatment of Localized Prostate Cancer Under Active Surveillance
- First Posted Date
- 2018-04-12
- Last Posted Date
- 2021-10-18
- Lead Sponsor
- Omnitura Therapeutics, Inc.
- Registration Number
- NCT03495479
A Study of Aneustat (OMN54) in Patients With Advanced Cancer and Lymphomas
Phase 1
Completed
- Conditions
- Neoplasms
- Interventions
- Drug: Aneustat (OMN54)
- First Posted Date
- 2012-03-15
- Last Posted Date
- 2015-04-08
- Lead Sponsor
- Omnitura Therapeutics, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT01555242
- Locations
- 🇨🇦
BC Cancer Agency-Vancouver Centre, Vancouver, British Columbia, Canada
News
No news found